Header Logo

Connection

RACHELLE DOODY to Amyloidosis

Back to Details
This is a "connection" page, showing publications RACHELLE DOODY has written about Amyloidosis.
RACHELLE DOODY
Connection Strength
0.783
Amyloidosis
  1. Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease. Alzheimers Res Ther. 2022 11 29; 14(1):178.
    View in: PubMed
    Score: 0.783
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.